Cohance Lifesciences Limited — Updates, 26-10-2025: General Updates
26-10-2025 | 06:04 pm
26-10-2025 | 06:04 pm
USFDA flagged issues at the Nacharam FDF unit, classifying it 'Official Action Indicated'. Remediation started. With <2% US revenue and <1% EBITDA from this unit, the company expects no material impact on operations.
No comments yet. Be the first to comment!
